Tectonic Therapeutic | AVRO - Ebitda

Aktienkurs
30.00
Täglich Wechseln
-0.83 -2.69%
Monatlich
41.58%
Jährlich
41.84%
Q1 Prognose
32.30




Ebitda Veränderung Datum
Akebia Therapeutics USD 14.03M 17.19M 2025-03
Alnylam Pharmaceuticals USD 145.22M 236.56M 2025-12
Celltrion KRW 374.56B 352.67B 2025-09
Cspc Pharmaceutical CNY 2.19B 21.88M 2024-12
Deva Holding AS TRY 882.9M 201.7M 2023-09
Dianthus Therapeutics USD -40.19M 5.36M 2025-09
Divis Laboratories Ltd INR 8.9B 20M 2025-12
Gilead Sciences USD 4.03B 628M 2025-09
Ionis Pharmaceuticals USD -157.12M 307.36M 2025-09
Kangmei Pharma CNY 17.3M 20.56M 2025-06
Karyopharm Therapeutics USD -26.2M 1.83M 2024-09
Knight Therapeutics CAD 24.45M 3.46M 2025-12
Laboratorios Farma EUR 34.94M 102.95M 2025-06
MacroGenics USD 21.95M 55.39M 2025-09
Malin Corporation EUR -1.1M 200K 2024-12
Medical Developments International AUD 1.78M 3.78M 2024-12
Neuren Pharmaceuticals AUD 11.14M 165.56M 2025-12
Organigram Holdings CAD 5.26M 884K 2025-12
Pfizer USD 6.08B 351M 2025-09
Pharma Mar EUR 44.96M 46.94M 2025-12
Qiagen NV USD 249.69M 56.53M 2025-12
Roche Holding CHF 12.68B 2.36B 2024-06
Sanofi EUR 4.84B 2.95B 2025-09
Sarepta Therapeutics USD -168.03M 294.45M 2025-09
Sartorius EUR 277.4M 30.5M 2025-12
Sino Biopharmaceutical CNY 2.59B 1.57B 2024-12
Takeda JPY 448.13B 173.98B 2025-12
Tilray USD 8.36M 1.82M 2025-09
Zealand Pharma A/S -727.47M 285.54M 2025-12
Zhangzhou Pientzehuang Pharmaceutical CNY 531.61M 658.23M 2025-06